Trials / Conditions / Neurogenic Orthostatic Hypotension

Neurogenic Orthostatic Hypotension

16 registered clinical trials studyying Neurogenic Orthostatic Hypotension — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study in Subjects With Neurogenic Orthostatic Hypotension NCT07089043	CuraSen Therapeutics, Inc.	Phase 2
Not Yet Recruiting	Controlled CO2 Inhalation in NOH NCT06751888	University of Calgary	N/A
Recruiting	CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study NCT05908760	University of Calgary	N/A
Withdrawn	Sinusoidal Galvanic Vestibular Stimulation for Neurogenic Orthostatic Hypotension / Syncope NCT04976101	Hackensack Meridian Health	N/A
Recruiting	CPAP for the Treatment of Supine Hypertension NCT05489575	Vanderbilt University Medical Center	N/A
Recruiting	Hypercapnia in Orthostatic Hypotension NCT05295810	University of Calgary	N/A
Recruiting	Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients NCT04620382	Vanderbilt University Medical Center	EARLY_Phase 1
Unknown	Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension NCT04128137	H.A.C. PHARMA	Phase 4
Completed	Brain Perfusion & Oxygenation in Parkinson's Disease With NOH NCT03229174	William Ondo, MD	Phase 4
Completed	Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH NCT03350659	Seoul National University Hospital	Phase 4
Completed	TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) NCT02705755	Theravance Biopharma	Phase 2
Completed	Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) NCT02784535	Vanderbilt University Medical Center	Phase 2
Recruiting	Natural History Study of Synucleinopathies NCT01799915	NYU Langone Health	—
Terminated	Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome NCT00977171	Chelsea Therapeutics	Phase 2
Completed	Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) NCT01132326	Chelsea Therapeutics	Phase 3
Completed	Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) NCT00738062	Chelsea Therapeutics	Phase 3